De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Dallah Healthcare Beheer
Beheer criteriumcontroles 1/4
De CEO Dallah Healthcare's is Ahmad bin Babaeer, benoemd in Apr2021, heeft een ambtstermijn van 3.5 jaar. bezit rechtstreeks 0.002% van de aandelen van het bedrijf, ter waarde SAR 305.15K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.3 jaar en 1.9 jaar.
Belangrijke informatie
Ahmad bin Babaeer
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | 3.5yrs |
| Eigendom CEO | 0.002% |
| Management gemiddelde ambtstermijn | 2.3yrs |
| Gemiddelde ambtstermijn bestuur | 1.9yrs |
Recente managementupdates
Recent updates
Do Dallah Healthcare's (TADAWUL:4004) Earnings Warrant Your Attention?
Sep 19
Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 14The Price Is Right For Dallah Healthcare Company (TADAWUL:4004)
Jul 18Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist
May 30We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Apr 16What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E
Mar 18Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes
Feb 25Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward
Oct 30Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return
Jul 26Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)
Apr 17Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Feb 06Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends
Dec 05We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Nov 01Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)
Aug 28Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger
Aug 12Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Jul 28Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%
May 26Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)
May 20Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Apr 16Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Feb 03Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Jan 10Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Oct 19Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Jul 09Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically
Jun 16Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher
May 02What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?
Mar 17Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?
Mar 02Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year
Feb 15Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?
Feb 01Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 05
Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price
Dec 22Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?
Nov 20CEO
Ahmad bin Babaeer (66 yo)
3.5yrs
Tenure
ر.س8,000
Compensatie
Dr. Ahmad bin Saleh Babaeer serves as the Chief Executive Officer of Dallah Healthcare Company since April 2021. Dr. Babaeer served as General Manager of Dallah Hospital at Dallah Healthcare Holding Co. Dr...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Director & General Medical Supervisor | no data | ر.س2.89m | 4.83% SAR 730.3m | |
| Chief Executive Officer | 3.5yrs | ر.س8.00k | 0.0019% SAR 294.9k | |
| Chief Financial Officer | 2.8yrs | geen gegevens | geen gegevens | |
| Chief Operating Officer | no data | geen gegevens | geen gegevens | |
| Chief Medical Officer | 7.8yrs | geen gegevens | geen gegevens | |
| C.S.O. | 1.6yrs | geen gegevens | geen gegevens | |
| Chief Commercial Officer | 1.8yrs | geen gegevens | geen gegevens | |
| Chief Digitization Officer | less than a year | geen gegevens | geen gegevens |
2.3yrs
Gemiddelde duur
71yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van 4004 wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.3 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Director & General Medical Supervisor | no data | ر.س2.89m | 4.83% SAR 730.3m | |
| Chairman of the Board | 11yrs | ر.س2.23m | 4.62% SAR 697.9m | |
| Vice Chairman of the Board | 1.9yrs | ر.س329.60k | 0.0016% SAR 235.9k | |
| Director | no data | ر.س413.33k | geen gegevens | |
| Director | no data | ر.س321.00k | geen gegevens | |
| Independent Director | 3.8yrs | ر.س347.00k | geen gegevens | |
| Director | 1.9yrs | geen gegevens | geen gegevens | |
| Director | 1.9yrs | geen gegevens | geen gegevens | |
| Director | 1.6yrs | geen gegevens | geen gegevens |
1.9yrs
Gemiddelde duur
60.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 4004 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.9 jaar), wat duidt op een nieuw bestuur.